Digoxin has been approved in the United States and in the European Union and in the Other Countries

Studies listed may include approved and non-approved uses, formulations or treatment regimens. Before prescribing any product mentioned in this Register, healthcare Professionals should consult prescribing information approved in their country (view UK and US information for Healthcare Professionals).

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.


digoxin studies

Select the study ID number to view the trial summary

Study IDPhaseTitle
CXA10017 I An open-label, non-randomised, single sequence study to investigate the effect of a New Chemical Entity (NCE) on the pharmacokinetic profile of digoxin in healthy subjects.
GR120008/901 I A Study to Evaluate the Effect of a High Fiber and a High Fat Meal on the Pharmacokinetics of LANOXIN† (digoxin) Elixir Pediatric in Healthy Adults
HM2006/00124/00 I A Study to Assess the Effect of Repeat Dose NCE on the Steady-State Pharmacokinetics and Pharmacodynamics of Digoxin in Healthy Subjects
SB-424323/007 I A study to assess the effect of repeat dosing of a New Chemical Entity (NCE) on the steady-state pharmacokinetics and pharmacodynamics of digoxin in healthy volunteers.
UM2007/00014/00 I An Open-Label, Randomized (with Respect to Different Dose of a NCE), Two Period Parallel Group Study to Evaluate the Potential Pharmacokinetic Interaction of Co-administered NCE and Digoxin in Healthy Subjects.